Home › Funds › Kepos Capital LP › NHIV

Kepos Capital LP position in NHIV

NEWHOLD INVTS CORP IV · Financials

Kepos Capital LP reported holding 74,997 shares of NHIV (NEWHOLD INVTS CORP IV) in its Q3 2026 13F filing — a position valued at US$757K, representing 1.08% of its reported portfolio and ranking #28 among its reported holdings. Kepos Capital LP has disclosed NHIV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)75.00K sh
Reported value held$757.47K
Portfolio Weight1.08%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kepos Capital LP's NHIV position evolved

Kepos Capital LP first disclosed a stake in NHIV in Q2 2026 at 74,997 shares (US$750K). The position peaked in Q3 2026 at 74,997 shares, worth US$757K. Across 2 filings, Kepos Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 74,997 shares valued at US$757K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 75.00K $750.00K New
Q3 2026 75.00K $757.47K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NHIV and 13F data

NHIV (NEWHOLD INVTS CORP IV) is a Financials company. 31 other funds we track also report a position in NHIV — the largest reported positions include Wealthspring Capital LLC (US$5.2M), Mint Tower Capital Management B.V. (US$4.5M), GRITSTONE ASSET MANAGEMENT LLC (US$754K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NHIV

All NHIV fund holders →

FAQ

How long has Kepos Capital LP held NHIV?

Kepos Capital LP has disclosed NHIV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Kepos Capital LP's current position in NHIV?

As of Q3 2026, Kepos Capital LP holds 75.00K shares of NHIV (NEWHOLD INVTS CORP IV), valued at $757.47K, representing 1.08% of its reported portfolio and ranking #28.

Has Kepos Capital LP been buying or selling NHIV?

In the latest 13F filing (Q3 2026), Kepos Capital LP held unchanged its position in NHIV. The position peaked in Q3 2026 at 75.00K shares.

Which other funds hold NHIV?

Other major institutional holders of NHIV include Wealthspring Capital LLC, Mint Tower Capital Management B.V., GRITSTONE ASSET MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.